butabarbital decreases consequences of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Coadministration of CYP3A4 inducers may reduce sufentanil amounts and efficacy, probably precipitating withdrawal syndrome in clients who've created phys